Gary J. Grover
18Patents
9h-index
17Co-inventors
65Inventor score
Filing activity: Sep 17, 1987 → Dec 10, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6916813B2 | (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase | Chemistry; Metallurgy | 57 | Expired |
| US4931464A | Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation | Human Necessities | 38 | Expired |
| US5140031A | Pyranyl cyanoguanidine derivatives | Chemistry; Metallurgy | 27 | Expired |
| US5679706A | Combination of a potassium channel activator and an antiarrhythmic agent | Human Necessities | 25 | Expired |
| US4962095A | Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation | Human Necessities | 25 | Expired |
| US5011837A | Aryl cyanoguanidines: potassium channel activators and method of making same | Chemistry; Metallurgy | 19 | Expired |
| US5643921A | Cardiopulmonary bypass and organ transplant using a potassium channel activator | Human Necessities | 14 | Expired |
| US5008284A | Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation | Human Necessities | 12 | Expired |
| US5066480A | Method of preventing or reducing adverse reactions to protamine using a thromboxane A.sub.2 receptor antagonist | Human Necessities | 11 | Expired |
| US5116851A | Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides | Chemistry; Metallurgy | 8 | Expired |
| US5278169A | Method of treating or prevention of fibrillation of the heart | Chemistry; Metallurgy | 7 | Expired |
| US5256688A | Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion | Human Necessities | 5 | Expired |
| US4931460A | Post-ischemic myocardial dysfunction using thromboxane A.sub.2 antagonists | Human Necessities | 5 | Expired |
| US5354764A | Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion | Human Necessities | 4 | Expired |
| US4975279A | Method of improving post-ischemic myocardial function using a thromboxane A2 antagonist in combination with a thrombolytic agent and combination | Human Necessities | 3 | Expired |
| US4857548A | Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A.sub.2 receptor antagonist | Human Necessities | 1 | Expired |
| USH1139H | Combination of a calcium channel blocker and thromboxane A.sub.2 | General | 0 | Active |
| US4820733A | Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A.sub.2 receptor antagonist | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.